ASCO: Platinum-Taxane Regimen No Benefit for Thymoma or Thymic Carcinoma
CHICAGO -- For treatment-naive advanced thymoma or thymic carcinoma, carboplatin (Paraplatin) and paclitaxel (Taxol) failed to achieve response rates approaching those reported in published trials of athracycline-based regimens.
Jun 05, 2008